Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

Confirm Password

About Us
Team
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?

By The North American Thrombosis Forum (NATF) FEATURING Christian Cruff

October 15, 2020

0 Comments

11th Annual Multimodality Cardiovascular Imaging for the Clinician

Sat, Dec 11, 2021

Northwestern Medicine Cardiovascular Care

17th Annual Heart Failure Holiday Symposium

Fri, Dec 10, 2021

64:45

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi

54:29

Terumo Interventional Systems

Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evaluation i…

Feat. J. Spertus

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almo…

Feat. R. DeFronzo

25:21

Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo

14:39

Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice

30:37

Cardiac Contractility Modulation

AAHFN 2021 – Failure is Not an Option: Considering Cardiac Contractility M…

Feat. M. Goldschmidt, L. Rathman

47:37

Medtronic

Workflow Changes and Patient Education Initiatives to Improve Reveal LINQ™…

67:39

Medtronic

Best Practices in Short-to-Long-Term Cardiac Monitor Conversion through CO…

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

47:43

Medtronic

My Patient's Short-Term Cardiac Monitor Delivered - How to Transition …

40:17

American College of Cardiology

Heart Failure with Preserved Ejection Fraction: Current Perspectives and O…

Feat. S. Shah

17:35

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhib…

Feat. B. Greenberg

12:23

American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Hospital…

Feat. M. Tipton

56:47

Medtronic

Operationalizing an AF Clinic During COVID-19

11:50

American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. Where …

Feat. M. Kittleson

35:35

Cardiac Contractility Modulation

AHA 2020 - Heart Failure Classification for Appropriate Device Therapy and…

Feat. W. Abraham, N. Raval, J. Singh

16:54

Cardiac Contractility Modulation

Cardiac Contractility Modulation: How it Works

Feat. J. Ehrlich, H. Levin

19:47

Complex Coronary Cases

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Use Trip…

Feat. U. Baber

41:21

Medtronic

Is There a Need for Devices that Detect, Reduce, and Respond to AF?

Feat. A. Al-Ahmad

Login

Login

Join VuMedi

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?

Related Content